ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 235 out of 1185

$674K Total Retail Price of All Prescriptions

Rank: 134 out of 1185

335 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,428 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
FUROSEMIDE 323 269 1 8
ZOLPIDEM TARTRATE 298 177 2 15
SIMVASTATIN 257 195 3 5
AMLODIPINE BESYLATE 224 198 4 1
METOPROLOL SUCCINATE 222 180 5 20
TRAMADOL HCL 206 97 6 16
OMEPRAZOLE 205 136 7 6
ATENOLOL 200 137 8 28
METFORMIN HCL 195 151 9 9
ALLOPURINOL 180 158 10 30
GABAPENTIN 161 98 11 13
LEVOTHYROXINE SODIUM 157 123 12 3
HYDROCODONE-ACETAMINOPHEN 153 78 S3 13 2
WARFARIN SODIUM 151 115 14 21
LISINOPRIL 142 122 15 4
MELOXICAM 140 99 16 27
LEVOFLOXACIN 138 100 17 109
RAMIPRIL 131 104 18 135
NAMENDA 123 120 19 43
SERTRALINE HCL 121 88 20 25
CRESTOR 116 81 21 23
POTASSIUM CHLORIDE 109 69 22 18
PANTOPRAZOLE SODIUM 108 76 23 58
HYDROCHLOROTHIAZIDE 98 75 24 12
PREDNISONE 88 62 25 33
NEXIUM 87 45 26 19
JANUVIA 85 78 27 68
GLIMEPIRIDE 84 69 28 49
CARVEDILOL 79 58 29 24
FLUTICASONE PROPIONATE 77 54 30 29
BENICAR 77 66 30 187
METOPROLOL TARTRATE 75 73 32 10
DIOVAN 75 60 32 37
RISPERIDONE 74 51 34 72
ADVAIR DISKUS 69 40 35 54
CYCLOBENZAPRINE HCL 68 33 R 36 53
CYMBALTA 67 32 37 44
ATORVASTATIN CALCIUM 65 47 38 11
AZITHROMYCIN 64 40 39 39
CLOPIDOGREL 60 52 40 31
BUPROPION XL 59 41 41 203
POLYETHYLENE GLYCOL 3350 58 42 42 60
ONGLYZA 53 49 43 250
ISOSORBIDE MONONITRATE ER 53 49 43 48
MONTELUKAST SODIUM 51 25 45 186
PLAVIX 51 48 45 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.